Log In
Print this Print this


Also known as: Eraxis/Vfend

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionCombination of anidulafungin and voriconazole antifungal
Molecular Target Beta 1,3-D-glucan synthase
Mechanism of ActionAntifungal agent
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase III
Standard IndicationAspergillus
Indication DetailsTreat aspergillus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today